S. Vaulont

发表

Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin.

B. Viollet, F. Tronche, C. Knauf, 2006, Endocrinology.

Role of the alpha2-isoform of AMP-activated protein kinase in the metabolic response of the heart to no-flow ischemia.

B. Viollet, J. Hoerter, L. Bertrand, 2006, American journal of physiology. Heart and circulatory physiology.

Hepatocyte Nuclear Factor-4α Involved in Type 1 Maturity-Onset Diabetes of the Young Is a Novel Target of AMP-Activated Protein Kinase

B. Viollet, S. Vaulont, I. Leclerc, 2001 .

Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness

S. Vaulont, P. Stenvinkel, A. D. de Francisco, 2009, NDT plus.

Role of AMPKalpha2 in basal, training-, and AICAR-induced GLUT4, hexokinase II, and mitochondrial protein expression in mouse muscle.

B. Viollet, J. Treebak, P. Schjerling, 2007, American journal of physiology. Endocrinology and metabolism.

Upstream Stimulatory Factors 1 and 2 activate the human hepatic lipase promoter via E-box dependent and independent mechanisms.

S. Vaulont, A. Verhoeven, Diederik van Deursen, 2009, Biochimica et biophysica acta.

Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs).

V. Nizet, E. Rankin, R. Johnson, 2007, The Journal of clinical investigation.

HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice.

C. Peyssonnaux, S. Vaulont, M. Simon, 2009, The Journal of clinical investigation.

Improvement of Insulin Action in Diabetic Transgenic Mice Selectively Overexpressing GLUT4 in Skeletal Muscle

M. Salminen, J. Girard, S. Vaulont, 1996, Diabetes.

Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models.

B. Viollet, M. Birnbaum, J. Wojtaszewski, 2001, Biochemical Society transactions.

Role of upstream stimulatory factors in regulation of renal transforming growth factor-beta1.

K. Sharma, S. Vaulont, Yanqing Zhu, 2005, Diabetes.

Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes

S. Vaulont, J. Deschemin, G. Ramey, 2009, Haematologica.

Smad6 and Smad7 are co-regulated with hepcidin in mouse models of iron overload.

S. Dooley, M. Muckenthaler, S. Vaulont, 2013, Biochimica et biophysica acta.

Inactive matriptase‐2 mutants found in IRIDA patients still repress hepcidin in a transfection assay despite having lost their serine protease activity

C. Beaumont, C. Oudin, B. Grandchamp, 2012, Human mutation.

Iron-deficiency anemia from matriptase-2 inactivation is dependent on the presence of functional Bmp6.

C. López-Otín, S. Vaulont, A. Ramsay, 2011, Blood.

Iron-deficiency anemia from matriptase-2 inactivation is dependent on the presence of functional Bmp 6 *

C. López-Otín, S. Vaulont, A. Ramsay, 2011 .

Hepcidin targets ferroportin for degradation in hepatocytes

S. Vaulont, B. Durel, G. Nicolas, 2010, Haematologica.

Iron deficiency anemia due to matriptase-2 inactivation is dependent upon the presence of functional Bmp 6 Short title : Matriptase-2 and Bmp 6 deficiency in mice

C. López-Otín, S. Vaulont, A. Ramsay, 2010 .

Deregulation of proteins involved in iron metabolism in hepcidin-deficient mice.

S. Vaulont, A. Kahn, G. Nicolas, 2005, Blood.

Hepcidin quantification: methods and utility in diagnosis.

S. Vaulont, M. Montes-Bayón, T. Konz, 2014, Metallomics : integrated biometal science.

[Deciphering the action mechanism of hepcidin].

S. Vaulont, G. Nicolas, 2005, Medecine sciences : M/S.

Hepcidin deficiency and iron deficiency do not alter tuberculosis susceptibility in a murine M.tb infection model

H. McShane, S. Vaulont, E. Stylianou, 2018, PloS one.

Effects of α‐AMPK knockout on exercise‐induced gene activation in mouse skeletal muscle

P. Neufer, Y. Hellsten, B. Viollet, 2005 .

Type 2 Diabetes, Metabolic Syndrome, Lipid Metabolism

Speakman, D. Withers, S. Vaulont, 2016 .

Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle.

P. Neufer, Y. Hellsten, B. Viollet, 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Disruption of the adenosine deaminase (ADA) gene using a dicistronic promoterless construct: Production of an ADA-deficient homozygote ES cell line

M. Evans, S. Vaulont, Samuel Daines, 1995, Transgenic Research.

Hepcidin is essential for alveolar macrophage function and is disrupted by smoke in a murine COPD model

Cloonan, J. Scandura, S. Vaulont, 2021 .

Copper Deficiency Leads to Anemia, Duodenal Hypoxia, Upregulation of HIF-2α and Altered Expression of Iron Absorption Genes in Mice

C. Peyssonnaux, S. Vaulont, J. Poupon, 2013, PloS one.

Deletion of HIF-2α in the enterocytes decreases the severity of tissue iron loading in hepcidin knockout mice.

C. Peyssonnaux, S. Vaulont, Pavle Matak, 2012, Blood.

Hepatic hypoxia-inducible factor-2 down-regulates hepcidin expression in mice through an erythropoietin-mediated increase in erythropoiesis

C. Peyssonnaux, S. Vaulont, P. Mayeux, 2012, Haematologica.

Hepcidin knockout mice fed with iron-rich diet develop chronic liver injury and liver fibrosis due to lysosomal iron overload.

C. Trautwein, P. Walther, S. Vaulont, 2014, Journal of hepatology.

Dietary and hormonal regulation of aldolase B gene expression.

A. Munnich, G. Reach, S. Vaulont, 1985, The Journal of clinical investigation.

Anti-lipolytic Action of AMP-activated Protein Kinase in Rodent Adipocytes*

B. Viollet, S. Vaulont, F. Foufelle, 2005, Journal of Biological Chemistry.

AICA-riboside induces apoptosis of pancreatic beta cells through stimulation of AMP-activated protein kinase

D. Pipeleers, H. Heimberg, S. Vaulont, 2003, Diabetologia.

Glucose Regulation of Gene Transcription*

M. Vasseur-Cognet, S. Vaulont, A. Kahn, 2000, The Journal of Biological Chemistry.

Hepatocyte nuclear factor-4alpha involved in type 1 maturity-onset diabetes of the young is a novel target of AMP-activated protein kinase.

B. Viollet, S. Vaulont, I. Leclerc, 2001, Diabetes.

The alpha2-5'AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal muscle and is responsive to glucose loading.

B. Viollet, D. Hardie, P. Schjerling, 2004, Diabetes.

AMP-activated protein kinase alpha2 deficiency affects cardiac cardiolipin homeostasis and mitochondrial function.

B. Viollet, J. Hoerter, S. Vaulont, 2007, Diabetes.

Rôles physiologiques de l’AMP-activated protein kinase (AMPK)

B. Viollet, F. Andreelli, S. Vaulont, 2003 .

cardiac cardiolipin homeostasis and mitochondrial function.

S. Vaulont, P. Mateo, A. Garnier, 2007 .

A tamoxifen‐inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver

M. Vasseur-Cognet, S. Vaulont, A. Kahn, 2002, Hepatology.

Glucose-dependent Liver Gene Expression in Upstream Stimulatory Factor 2 −/− Mice*

S. Vaulont, A. Kahn, M. Raymondjean, 1997, The Journal of Biological Chemistry.

Dietary and hormonal regulation of L-type pyruvate kinase gene expression in rat small intestine.

A. Munnich, G. Reach, S. Lyonnet, 1987, European journal of biochemistry.

Insulin resistance and adipose tissue inflammation induced by a high-fat diet are attenuated in the absence of hepcidin

S. Vaulont, A. Mckie, M. Jacob, 2021, bioRxiv.

Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle.

B. Viollet, P. Schjerling, J. Wojtaszewski, 2004, The Journal of biological chemistry.

Maintenance of red blood cell integrity by AMP‐activated protein kinase α1 catalytic subunit

B. Viollet, M. Foretz, F. Andris, 2010, FEBS letters.

Combinatorial crosstalk of transacting factors binding to the L-type pyruvate kinase promoter elements analysed in vitro.

S. Vaulont, A. Kahn, M. Raymondjean, 1992, Biochemical and biophysical research communications.

Essential Role in Vivo of Upstream Stimulatory Factors for a Normal Dietary Response of the Fatty Acid Synthase Gene in the Liver*

S. Vaulont, A. Kahn, M. Casado, 1999, The Journal of Biological Chemistry.

Analysis by cell-free transcription of the liver-specific pyruvate kinase gene promoter

S. Vaulont, A. Kahn, M. Raymondjean, 1989, Molecular and cellular biology.

The microbiota shifts the iron sensing of intestinal cells

S. Vaulont, Z. Karim, P. Langella, 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

A possible role for AMP-activated protein kinase in exercise-induced glucose utilization: insights from humans and transgenic animals.

B. Viollet, J. Wojtaszewski, S. Vaulont, 2001, Biochemical Society transactions.

Iron absorption in hepcidin1 knockout mice.

R. Simpson, S. Vaulont, G. Latunde-Dada, 2011, The British journal of nutrition.

Iron Homeostasis and Inflammatory Status in Mice Deficient for the Cystic Fibrosis Transmembrane Regulator

S. Vaulont, F. Brouillard, J. Deschemin, 2015, PloS one.

Matriptase-2 is essential for hepcidin repression during fetal life and postnatal development in mice to maintain iron homeostasis.

C. López-Otín, S. Vaulont, A. Ramsay, 2014, Blood.

Role of Hepcidin in the Setting of Hypoferremia during Acute Inflammation

S. Vaulont, J. Deschemin, 2013, PloS one.

Severe iron deficiency anemia in transgenic mice expressing liver hepcidin

C. Beaumont, B. Grandchamp, S. Vaulont, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Iron Regulator Hepcidin Impairs Macrophage-Dependent Cardiac Repair After Injury

D. Voehringer, C. Peyssonnaux, S. Vaulont, 2019, Circulation.

Hepcidin‐dependent and hepcidin‐independent regulation of erythropoiesis in a mouse model of anemia of chronic inflammation

C. Cheadle, C. Civin, S. Vaulont, 2014, American journal of hematology.

hepcidin-deficient mice Deregulation of proteins involved in iron metabolism in

S. Vaulont, G. Nicolas, D. Lou, 2010 .

Brief report Hepcidin, a candidate modiﬁer of the hemochromatosis phenotype in mice

N. Andrews, S. Vaulont, A. Kahn, 2004 .

Exploration of a liver-specific, glucose/insulin-responsive promoter in transgenic mice.

S. Vaulont, A. Kahn, M. Cuif, 1993, The Journal of biological chemistry.

A role for hepcidin in the anemia caused by Trypanosoma brucei infection

S. Vaulont, J. Tavares, D. Costa, 2020, Haematologica.

Iron overload in Hepc1 −/− mice is not impairing glucose homeostasis

B. Viollet, S. Vaulont, B. Durel, 2007, FEBS letters.

[To prevent and cure the iron overloads, the hopes of hepcidin].

S. Vaulont, L. Viatte, 2006, Medecine sciences : M/S.

Interleukin-6 contributes to hepcidin mRNA increase in response to exercise.

X. Bigard, S. Vaulont, N. Koulmann, 2012, Cytokine.

Regulation of iron metabolism in Hamp−/− mice in response to iron-deficient diet

R. Simpson, S. Vaulont, G. Latunde-Dada, 2013, European Journal of Nutrition.

Iron metabolism in hepcidin1 knockout mice in response to phenylhydrazine-induced hemolysis.

R. Simpson, S. Vaulont, G. Latunde-Dada, 2012, Blood cells, molecules & diseases.

Targeted disruption of hepcidin in the liver recapitulates the hemochromatotic phenotype.

C. Peyssonnaux, S. Vaulont, L. Viatte, 2014, Blood.

[Roles of bacterial and mammalian siderophores in host-pathogen interactions].

S. Vaulont, I. Schalk, 2015, Medecine sciences : M/S.

Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis

N. Andrews, C. Beaumont, S. Vaulont, 2003, Nature Genetics.

Neutrophils from hereditary hemochromatosis patients are protected from iron excess and are primed.

D. Borderie, N. Boussetta, C. Peyssonnaux, 2020, Blood advances.

Smad7, Id1, and Atoh8 in the mouse liver Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6,

J. Mosser, A. Monnier, S. Vaulont, 2013 .

Iron- and Hepcidin-Independent Downregulation of the Iron Exporter Ferroportin in Macrophages during Salmonella Infection

D. Malo, S. Vaulont, O. Thibaudeau, 2017, Front. Immunol..

Hepcidin knockout mice spontaneously develop chronic pancreatitis owing to cytoplasmic iron overload in acinar cells

C. Trautwein, S. Vaulont, J. Haybaeck, 2017, The Journal of pathology.

Iron Inhibits the Translation and Activity of the Renal Epithelial Sodium Channel

A. Alli, S. Vaulont, Ling Yu, 2022, Biology.

Is EPO therapy able to correct iron deficiency anaemia caused by matriptase‐2 deficiency?

G. Velasco, C. Beaumont, B. Grandchamp, 2011, British journal of haematology.

Dependence of hepatocyte‐specific gene expression on cell‐cell interactions in primary culture.

A. Munnich, C. Guguen-Guillouzo, D. Glaise, 1985, The EMBO journal.

C. Peyssonnaux, S. Vaulont, Pavle Matak, 2011, Blood cells, molecules & diseases.

Hepcidin, a key regulator of iron metabolism

C. Beaumont, S. Vaulont, G. Nicolas, 2003 .

Expression of c-myc is under dietary control in rat liver.

N. Denis, A. Kitzis, S. Lyonnet, 1987, Oncogene research.

Elements responsible for hormonal control and tissue specificity of L-type pyruvate kinase gene expression in transgenic mice

S. Vaulont, A. Kahn, M. Cognet, 1992, Molecular and cellular biology.

The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity.

B. Viollet, M. Birnbaum, D. Carling, 2003, The Journal of clinical investigation.

[Reversible metalation of a bis-disulfide analogue of the Cys*-X-Cys* hepcidin binding site: structural characterisation of the related copper complex].

S. Vaulont, P. Roussel, E. Galardon, 2010, Annales pharmaceutiques francaises.

Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver.

Jean Mosser, J. Mosser, A. Monnier, 2008, Blood.

UV-induced Expression of Key Component of the Tanning Process, the POMC and MC1R Genes, Is Dependent on the p-38-activated Upstream Stimulating Factor-1 (USF-1)*

D. Bennett, E. Sviderskaya, S. Vaulont, 2004, Journal of Biological Chemistry.

Hepcidin knockout mice as a model of iron-overload associated liver disease

K. Lackner, S. Vaulont, G. Adler, 2011 .

The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation.

Gaël Nicolas, Isabelle Devaux, C. Beaumont, 2002, The Journal of clinical investigation.

Induced adiposity and adipocyte hypertrophy in mice lacking the AMP-activated protein kinase-alpha2 subunit.

B. Viollet, H. Sul, S. Vaulont, 2004, Diabetes.

Transcriptional and post-transcriptional regulation of L-type pyruvate kinase gene expression in rat liver.

A. Munnich, S. Vaulont, A. Kahn, 1986, The Journal of biological chemistry.

The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels.

Vladimir Valera Romero, W Marston Linehan, B. Viollet, 2011, Cancer cell.

Mouse USF1 gene cloning: comparative organization within the c-myc gene family

S. Vaulont, A. Kahn, M. Raymondjean, 1996, Mammalian Genome.

Transcriptional control of metabolic regulation genes by carbohydrates

S. Vaulont, A. Kahn, 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice

C. Beaumont, B. Grandchamp, S. Vaulont, 2001, Proceedings of the National Academy of Sciences of the United States of America.

USF-1 Is Critical for Maintaining Genome Integrity in Response to UV-Induced DNA Photolesions

S. Vaulont, S. Corre, M. Galibert, 2012, PLoS genetics.

Structure of the rat L-type pyruvate kinase gene.

J. Marie, S. Vaulont, A. Kahn, 1987, Journal of molecular biology.

Investigation of the role of interleukin-6 and hepcidin antimicrobial peptide in the development of anemia with age

C. Cheadle, T. Ganz, C. Civin, 2013, Haematologica.

Molecular Regulation of Systemic Iron Metabolism

T. Ganz, S. Vaulont, 2012 .

Chronic hepcidin induction causes hyposideremia and alters the pattern of cellular iron accumulation in hemochromatotic mice.

N. Andrews, H. Bujard, K. Schönig, 2006, Blood.

Iron‐ and inflammation‐induced hepcidin gene expression in mice is not mediated by Kupffer cells in vivo

L. Rénia, S. Vaulont, A. Kahn, 2005, Hepatology.

Hepcidin, a new iron regulatory peptide.

C. Beaumont, S. Vaulont, A. Kahn, 2002, Blood cells, molecules & diseases.

Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis.

S. Vaulont, A. Kahn, G. Hamard, 2006, Blood.

DNase-I hypersensitivity analysis of the L-type pyruvate kinase gene in rats and transgenic mice.

S. Vaulont, A. Kahn, M. Raymondjean, 1992, European journal of biochemistry.

Positive and negative regulation of gene expression by insulin and glucagon: the model of L-type pyruvate kinase gene.

S. Vaulont, A. Kahn, M. Raymondjean, 1991, Biochimie.

In vivo hormonal control of L-type pyruvate kinase gene expression. Effects of glucagon, cyclic AMP, insulin, cortisone, and thyroid hormones on the dietary induction of mRNAs in the liver.

A. Munnich, G. Reach, J. Marie, 1984, The Journal of biological chemistry.

Age-dependent retinal iron accumulation and degeneration in hepcidin knockout mice.

J. Connor, S. Vaulont, J. Beard, 2011, Investigative ophthalmology & visual science.

Differential Roles of Upstream Stimulatory Factors 1 and 2 in the Transcriptional Response of Liver Genes to Glucose*

S. Vaulont, A. Kahn, M. Raymondjean, 1998, The Journal of Biological Chemistry.

Knockout of the α2 but Not α1 5′-AMP-activated Protein Kinase Isoform Abolishes 5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranosidebut Not Contraction-induced Glucose Uptake in Skeletal Muscle*

Peter Schjerling, Jørgen F. P. Wojtaszewski, B. Viollet, 2004, Journal of Biological Chemistry.

Hepcidin Is Essential for Alveolar Macrophage Function and Is Disrupted by Smoke in a Murine Chronic Obstructive Pulmonary Disease Model

P. Barnes, J. Scandura, S. Vaulont, 2020, The Journal of Immunology.

Hepcidin as a Major Component of Renal Antibacterial Defenses against Uropathogenic Escherichia coli.

E. Denamur, M. Sari, C. Beaumont, 2016, Journal of the American Society of Nephrology : JASN.

Oncostatin M is a potent inducer of hepcidin, the iron regulatory hormone

S. Vaulont, F. Verdier, P. Mayeux, 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Hepcidin, the iron watcher.

S. Vaulont, L. Viatte, 2009, Biochimie.

Cre-mediated germline mosaicism: a method allowing rapid generation of several alleles of a target gene.

S. Vaulont, C. Lenzner, M. Holzenberger, 2000, Nucleic acids research.

Production of biologically active forms of recombinant hepcidin, the iron‐regulatory hormone

M. Sari, S. Vaulont, M. Jaouen, 2008, The FEBS journal.

Transferrin receptor 1 mRNA is downregulated in placenta of hepcidin transgenic embryos

C. Beaumont, B. Grandchamp, S. Vaulont, 2004, FEBS letters.

Low transferrin levels predict heightened inflammation in patients with COVID-19: New insights

C. Peyssonnaux, S. Vaulont, J. Saleh, 2021, International Journal of Infectious Diseases.

Of mice and men: the iron age.

S. Vaulont, A. Kahn, D. Lou, 2005, The Journal of clinical investigation.

Hepcidin, a candidate modifier of the hemochromatosis phenotype in mice.

N. Andrews, S. Vaulont, A. Kahn, 2004, Blood.

AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons.

G. Barsh, B. Viollet, J. Speakman, 2007, The Journal of clinical investigation.

Physiopathological changes of ferritin mRNA density and distribution in hippocampal astrocytes in the mouse brain

P. Mailly, M. Cohen-Salmon, S. Vaulont, 2022, bioRxiv.

Suppression of Hepcidin Expression and Iron Overload Mediate Salmonella Susceptibility in Ankyrin 1 ENU-Induced Mutant

D. Malo, M. Paquet, S. Vaulont, 2012, PloS one.

Pulmonary Iron Homeostasis in Hepcidin Knockout Mice

C. Peyssonnaux, S. Vaulont, J. Deschemin, 2017, Front. Physiol..

Proteins binding to the liver-specific pyruvate kinase gene promoter. A unique combination of known factors.

S. Vaulont, A. Kahn, M. Raymondjean, 1989, Journal of molecular biology.

Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia.

M. Burdick, T. Ganz, S. Vaulont, 2017, JCI insight.

Pro-hepcidin is unable to degrade the iron exporter ferroportin unless maturated by a furin-dependent process.

M. Sari, S. Vaulont, B. Durel, 2009, Journal of hepatology.

Functional differences between hepcidin 1 and 2 in transgenic mice.

G. Grimber, S. Vaulont, A. Kahn, 2004, Blood.

Essential role of systemic iron mobilization and redistribution for adaptive thermogenesis through HIF2-α/hepcidin axis

T. Helikar, S. Vaulont, Soonkyu Chung, 2021, Proceedings of the National Academy of Sciences.

AMPK is not required for the effect of metformin on the inhibition of BMP6-induced hepcidin gene expression in hepatocytes

B. Viollet, M. Foretz, S. Vaulont, 2017, Scientific Reports.

Increased intracellular iron in mouse primary hepatocytes in vitro causes activation of the Akt pathway but decreases its response to insulin.

S. Vaulont, A. Mckie, M. Jacob, 2018, Biochimica et biophysica acta. General subjects.

Dendritic cell–derived hepcidin sequesters iron from the microbiota to promote mucosal healing

N. Ajami, H. Sokol, T. Arvedson, 2020, Science.

Hepcidin is localised in gastric parietal cells, regulates acid secretion and is induced by Helicobacter pylori infection

T. Barth, C. Peyssonnaux, S. Vaulont, 2011, Gut.

Enhanced insulin signaling and its downstream effects in iron-overloaded primary hepatocytes from hepcidin knock-out mice.

S. Vaulont, A. Mckie, M. Jacob, 2019, Biochimica et biophysica acta. Molecular cell research.

Expression and purification of a new recombinant camel hepcidin able to promote the degradation of the iron exporter ferroportin1.

M. Sari, S. Vaulont, M. N. Marzouki, 2015, Protein expression and purification.

Dual cardiac contractile effects of the alpha2-AMPK deletion in low-flow ischemia and reperfusion.

B. Viollet, J. Hoerter, L. Bertrand, 2007, American journal of physiology. Heart and circulatory physiology.

Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver.

B. Viollet, M. Foretz, F. Andreelli, 2005, Diabetes.

Transcriptional regulation of adipocyte hormone-sensitive lipase by glucose.

P. Rouet, S. Vaulont, D. Langin, 2002, Diabetes.

Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation.

Jean Girard, B. Viollet, J. Girard, 2005, The Journal of clinical investigation.

Hepatic peroxisome proliferator-activated receptor γ coactivator 1α and hepcidin are coregulated in fasted/refed states in mice.

B. Viollet, M. Foretz, S. Vaulont, 2012, Clinical Chemistry.

Haptoglobin is degraded by iron in C57BL/6 mice: a possible link with endoplasmic reticulum stress.

M. Foretz, S. Vaulont, G. Ramey, 2007, Blood cells, molecules & diseases.

Synthesis and biological activity of mouse hepcidin peptide analogs containing three disulfide bridges: manual and microwave-assisted solid-phase peptide synthesis.

M. Sari, S. Vaulont, Sunanda Chatterjee, 2012, Protein and peptide letters.

Hepcidin deficiency in mice impairs white adipose tissue browning possibly due to a defect in de novo adipogenesis

B. Galy, C. Peyssonnaux, S. Vaulont, 2023, Scientific Reports.

Cyclic AMP as a transcriptional inhibitor of upper eukaryotic gene transcription.

A. Munnich, G. Reach, P. Barbry, 1984, Biochemical and biophysical research communications.

Pgc-1␣ Has Recently Emerged Homocysteine as a Cause of Ischemic Heart Disease: the Door Remains Open

B. Viollet, M. Foretz, S. Vaulont, 2012 .

Expression and purification of a new recombinant camel hepcidin able to promote the degradation of the iron exporter ferroportin1.

M. Sari, S. Vaulont, Aymen Ezzine, 2015, Protein expression and purification.

Hepcidin regulates intrarenal iron handling at the distal nephron.

C. Beaumont, L. Gouya, H. Puy, 2013, Kidney international.

Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver.

J. Mosser, A. Monnier, S. Vaulont, 2008, Blood.

Transient transcriptional inhibition of the transferrin gene by cyclic AMP

A. Munnich, P. Brissot, S. Vaulont, 1985, FEBS letters.

AMP-Activated Protein Kinase α2 Deficiency Affects Cardiac Cardiolipin Homeostasis and Mitochondrial Function

B. Viollet, J. Hoerter, S. Vaulont, 2007, Diabetes.

Control of Hepatic Gene Expression at Both Transcriptional and Posttranscriptional Levels by cAMP

A. Munnich, S. Vaulont, A. Kahn, 1986 .